cGAS- STINGは,染色体不安定がんのIL-6依存生存率を左右する
Christy Hong1, Michael Schubert1,2, Andréa E Tijhuis1
1European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Nature
|June 15, 2022
まとめ
染色体不安定性 (CIN) は癌の進行を促します トシリズマブによるIL-6シグナリングの標的化は,CIN陽性三重陰性乳がんの成長を選択的に停止させ,新たな治療戦略を明らかにする.
科学分野:
- 腫瘍学
- 免疫学
- 細胞生物学
背景:
- 染色体不安定性 (CIN) はがんの特徴であり,がんの進化,転移,治療抵抗性を引き起こす.
- cGAS-STING経路は,典型的には腫瘍抑制剤であり,CIN誘発のDNA放出によって活性化されますが,腫瘍ではまれに無活性化されます.
- 癌の進行におけるcGAS- STINGの役割とその不活性化の原因は不明である.
研究 の 目的:
- CIN がん細胞における cGAS-STING 信号伝達の役割を調査する.
- CINとcGAS- STINGの活性化に関連する治療上の脆弱性を特定する.
- CIN誘発がんにおけるIL-6信号の標的化の可能性を調査する.
主な方法:
- CINの三重陰性乳がん (TNBC) 細胞におけるcGAS- STING信号の不活性化
- CIN細胞におけるIL-6-STAT3およびNF-κBシグナル伝達経路の分析
- CIN陽性のTNBC細胞と腫瘍をIL-6受容体阻害剤トシリズマブで治療する.
主要な成果:
- cGAS- STINGのシグナリングの不活性化は,CIN陽性のTNBC細胞の生存を選択的に低下させた.
- CINは,cGAS- STINGと非正規のNF- kB経路に依存するIL-6- STAT3シグナリングを誘発する.
- トシリズマブ治療は選択的にCIN陽性TNBC細胞の増殖を抑制し,体内で腫瘍の増殖を遅らせました.
- この脆弱性は,高いIL-6/ IL-6R発現を持つ他の癌型でも維持された.
結論:
- cGAS-STINGのシグナル伝達は,CIN主導の癌において,腫瘍原性特性を表しており,その不活性化を説明する.
- トシリズマブによるIL-6シグナリングの標的化は,IL-6Rを過剰に発現するCIN陽性がんに対する潜在的な治療戦略である.
- この研究は,染色体不安定な癌の標的となる脆弱性を明らかにした.
関連する概念動画
02:40Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
01:01Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
01:06Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
01:31The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
01:20The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K